Literature DB >> 10802804

Migraine with aura and white matter abnormalities: Notch3 mutation.

M Ceroni1, T E Poloni, S Tonietti, D Fabozzi, C Uggetti, F Frediani, F Simonetti, A Malaspina, D Alimonti, M Celano, M Ferrari, P Carrera.   

Abstract

The authors report on an Italian family with eight affected members who show autosomal dominant migraine with prolonged visual, sensory, motor, and aphasic aura. These symptoms are associated with white matter abnormalities on brain MRI. All living affected members carry a Notch3 mutation (Arg153Cys) previously reported in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). White matter abnormalities occur in a variable percentage of the general migraine population; CADASIL should be suspected in migraineurs with prolonged atypical aura and white matter abnormalities.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10802804     DOI: 10.1212/wnl.54.9.1869

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Current issues in migraine genetics.

Authors:  Jee-Young Lee; Manho Kim
Journal:  J Clin Neurol       Date:  2005-04-30       Impact factor: 3.077

Review 2.  Diagnostic criteria for CADASIL in the International Classification of Headache Disorders (ICHD-II): are they appropriate?

Authors:  Simona Sacco; Diana Degan; Antonio Carolei
Journal:  J Headache Pain       Date:  2010-03-12       Impact factor: 7.277

3.  Combined network pharmacology and virtual reverse pharmacology approaches for identification of potential targets to treat vascular dementia.

Authors:  Alexey A Lagunin; Sergey M Ivanov; Tatyana A Gloriozova; Pavel V Pogodin; Dmitry A Filimonov; Sandeep Kumar; Rajesh K Goel
Journal:  Sci Rep       Date:  2020-01-14       Impact factor: 4.379

Review 4.  Impact of ESR1 Gene Polymorphisms on Migraine Susceptibility: A Meta-Analysis.

Authors:  Li Li; Ruozhuo Liu; Zhao Dong; Xiaolin Wang; Shengyuan Yu
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.